Glucose Control: Key Factor for Decreased Cancer Risk in Obesity

In obesity and type 2 diabetes, good glucose control is found to be the key for reduction of cancer risk, revealed study.

In obesity and type 2 diabetes, good glucose control is found to be the key for reduction of cancer risk, revealed by a University of Gothenburg study.

That obesity is a risk factor for both type 2 diabetes and several types of cancer is a known fact. Similarly, intentional weight loss through, for example, bariatric surgery often results in amelioration of diabetes and many patients achieve normal blood-glucose control.

Test Your Knowledge on Gastric Cancer
Gastric cancer is also called stomach cancer as it occurs most commonly in the mucus producing cells lining the stomach. It is the seventh most common cancer among women and 5th most common cancer among men in India. A lot of research has been initiated into finding treatment measures and for reducing the risk for this type of cancer. In a study in China, it was found that cabbages and potatoes reduce the risk of gastric cancer. Studies such as these aid in controlling the incidence of this type of cancer.

‘The global epidemic of both obesity and diabetes leads to an increased risk of cancer, as well as an increased risk of premature death.’

In patients with obesity, cancer risk, too, can be reduced after major, long-lasting weight loss. However, there have been relatively few studies on the association between weight loss, risk of cancer, and glucose control in patients with both obesity and type 2 diabetes.

The present study, published in the journal Diabetes Care, used data from the “SOS” (Swedish Obese Subjects) intervention trial, which is led and coordinated from the University of Gothenburg, as well as data from other sources, such as the Swedish Cancer Registry.

Cancer risk 60 percent lower

How to Lose Weight?
Slide show which explains obesity causes and tips on how to lose weight. Exercising before breakfast is most effective for weight loss.

The researchers studied a group of 393 people with type 2 diabetes who underwent bariatric surgery, and compared them with a control group of 308 people with the same clinical characteristics; that is, they had severe obesity and type 2 diabetes, but had not undergone bariatric surgery. In other respects, such as in terms of gender composition, blood glucose, and smoking, the two groups were comparable.

In the surgery group, 68 individuals (approximately 17 percent) developed cancer in parallel with a significant weight loss. The corresponding emerging cancer cases in the control group amounted to 74 (24 percent), while these individuals retained their condition of severe obesity. The median follow-up period was 21 years. Overall, the risk of getting cancer was 37 percent lower in the group that underwent obesity surgery.

Diabetes Risk Assessment Calculator
Almost one-third of the people are unaware of the risk factors of diabetes. Find out if you run the risk of diabetes by using Diabetes Risk Assessment calculator.

However, the largest difference was observed when cancer risk was analyzed in the patients who achieved normal glucose control and had no relapse of diabetes over a 10-year period. Among these patients, the incidence of cancer was only 12 out of 102 (12 percent), against 75 out of 335 (22 percent) in the group whose diabetes had recurred in the same period. Thus, the results show a 60% reduction in cancer risk in the group where normal glucose control was maintained over 10 years.

Guidance for preventing cancer

Cancer Prevention thro' Lifestyle Changes
Did u know that simple changes in lifestyle could lower your cancer risks? Find out how!

“What we see is that, among patients with type 2 diabetes, many cancer cases are preventable. These results are an important contribution that enhances our understanding of the connection between glucose control and cancer prevention,” says Kajsa Sjöholm, associate professor of molecular medicine at Sahlgrenska Academy, University of Gothenburg, and the study’s first author.

Magdalena Taube, associate professor of molecular medicine at Sahlgrenska Academy, University of Gothenburg, is the senior author of the study.

“It has been estimated that, over the next 10 to 15 years, obesity may cause more cancer cases than smoking in several countries. This is a clear illustration of how serious the condition is,” she says.

“Strategies are need to prevent this development, and our results can provide vital guidance for prevention of cancer in patients with obesity and type 2 diabetes,” Taube concludes.

Source-Eurekalert